cyproterone acetate has been researched along with Growth Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furusho, K; Kawai, M; Momoi, T; Muroi, J; Sasaki, H; Yamanaka, C; Yorifuji, T | 1 |
| Anzo, M; Hasegawa, T; Ishii, T; Matsuo, N; Sasaki, G; Sato, S; Tamai, S | 1 |
| Fujimoto, M; Kato, K; Nakagomi, Y; Ohta, M; Ohyama, K; Yamori, T | 1 |
| Hibi, I; Shizume, K; Tanae, A; Tanaka, T; Yoshizawa, A | 1 |
4 other study(ies) available for cyproterone acetate and Growth Disorders
| Article | Year |
|---|---|
Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
Topics: Androgen Antagonists; Body Height; Child; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Growth Disorders; Growth Hormone; Humans; Male; Puberty; Retrospective Studies; Treatment Failure | 1998 |
Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
Topics: Administration, Inhalation; Administration, Oral; Body Height; Buserelin; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Growth Disorders; Hamartoma; Humans; Hypothalamic Diseases; Magnetic Resonance Imaging; Male; Progesterone Congeners; Puberty, Precocious; Treatment Outcome; Twins, Monozygotic | 1999 |
Effect of cyproterone acetate on active and inactive renin secretion in patients with precocious puberty and genetic short stature.
Topics: Androgen Antagonists; Child; Cyproterone; Cyproterone Acetate; Enzyme Precursors; Female; Growth Disorders; Humans; Puberty, Precocious; Renin; Renin-Angiotensin System | 1991 |
Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
Topics: Adolescent; Age Factors; Analysis of Variance; Androgen Antagonists; Body Height; Child; Cyproterone; Cyproterone Acetate; Growth; Growth Disorders; Growth Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty | 1990 |